These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27826877)

  • 1. Antimicrobial Stewardship and Environmental Decontamination for the Control of Clostridium difficile Transmission in Healthcare Settings.
    Bintz J; Lenhart S; Lanzas C
    Bull Math Biol; 2017 Jan; 79(1):36-62. PubMed ID: 27826877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile: improving the prevention paradigm in healthcare settings.
    Vassallo A; Tran MC; Goldstein EJ
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1087-102. PubMed ID: 25109301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting.
    Boyce JM; Havill NL; Otter JA; McDonald LC; Adams NM; Cooper T; Thompson A; Wiggs L; Killgore G; Tauman A; Noble-Wang J
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):723-9. PubMed ID: 18636950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment.
    Davies A; Pottage T; Bennett A; Walker J
    J Hosp Infect; 2011 Mar; 77(3):199-203. PubMed ID: 21130521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for additional investigation of room decontamination processes.
    Po JL; Carling PC
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):776-7. PubMed ID: 20521961
    [No Abstract]   [Full Text] [Related]  

  • 6. Vital signs: preventing Clostridium difficile infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(9):157-62. PubMed ID: 22398844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model.
    Nelson RE; Jones M; Leecaster M; Samore MH; Ray W; Huttner A; Huttner B; Khader K; Stevens VW; Gerding D; Schweizer ML; Rubin MA
    PLoS One; 2016; 11(3):e0152248. PubMed ID: 27031464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission.
    Stephenson B; Lanzas C; Lenhart S; Day J
    J Math Biol; 2017 Dec; 75(6-7):1693-1713. PubMed ID: 28484801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
    Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
    BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures to control and prevent Clostridium difficile infection.
    Gerding DN; Muto CA; Owens RC
    Clin Infect Dis; 2008 Jan; 46 Suppl 1():S43-9. PubMed ID: 18177221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new virulent clone of Clostridium difficile is a challenge for Danish hospitals].
    Schønheyder HC; Kristensen B
    Ugeskr Laeger; 2009 May; 171(19):1578. PubMed ID: 19419636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nosocomial acquisition of Clostridium difficile infections].
    Feldman J; Yaretzky A; Alterman P
    Harefuah; 1994 Feb; 126(3):121-5, 176. PubMed ID: 8168741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections].
    Barbut F; Petit JC
    Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing transmission of Clostridium difficile: is the answer blowing in the wind?
    Donskey CJ
    Clin Infect Dis; 2010 Jun; 50(11):1458-61. PubMed ID: 20415566
    [No Abstract]   [Full Text] [Related]  

  • 15. Environmental control to reduce transmission of Clostridium difficile.
    Mayfield JL; Leet T; Miller J; Mundy LM
    Clin Infect Dis; 2000 Oct; 31(4):995-1000. PubMed ID: 11049782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncologic aspects of Clostridium difficile].
    Telekes A
    Orv Hetil; 2016 Jul; 157(28):1110-6. PubMed ID: 27397423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold-air atmospheric pressure plasma against Clostridium difficile spores: a potential alternative for the decontamination of hospital inanimate surfaces.
    Claro T; Cahill OJ; O'Connor N; Daniels S; Humphreys H
    Infect Control Hosp Epidemiol; 2015 Jun; 36(6):742-4. PubMed ID: 25782039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards.
    Shapey S; Machin K; Levi K; Boswell TC
    J Hosp Infect; 2008 Oct; 70(2):136-41. PubMed ID: 18694613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic stewardship and Clostridium difficile-associated disease.
    Nuila F; Cadle RM; Logan N; Musher DM;
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1096-7. PubMed ID: 18947324
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores.
    Barbut F; Menuet D; Verachten M; Girou E
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):507-14. PubMed ID: 19379098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.